These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34965371)

  • 41. How Are Epigenetic Modifications Related to Cardiovascular Disease in Older Adults?
    Gharipour M; Mani A; Amini Baghbahadorani M; de Souza Cardoso CK; Jahanfar S; Sarrafzadegan N; de Oliveira C; Silveira EA
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetics for the pediatric cardiologist.
    Spearman AD
    Congenit Heart Dis; 2017 Dec; 12(6):828-833. PubMed ID: 28984030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiation-induced cardiovascular disease: an overlooked role for DNA methylation?
    Sallam M; Benotmane MA; Baatout S; Guns PJ; Aerts A
    Epigenetics; 2022 Jan; 17(1):59-80. PubMed ID: 33522387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atherosclerosis and flow: roles of epigenetic modulation in vascular endothelium.
    Lee DY; Chiu JJ
    J Biomed Sci; 2019 Aug; 26(1):56. PubMed ID: 31387590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic Remodeling in Obesity-Related Vascular Disease.
    Masi S; Ambrosini S; Mohammed SA; Sciarretta S; Lüscher TF; Paneni F; Costantino S
    Antioxid Redox Signal; 2021 May; 34(15):1165-1199. PubMed ID: 32808539
    [No Abstract]   [Full Text] [Related]  

  • 46. Epigenetics in the development, modification, and prevention of cardiovascular disease.
    Whayne TF
    Mol Biol Rep; 2015 Apr; 42(4):765-76. PubMed ID: 25205125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetics: a tool to understand diet-related cardiovascular risk?
    Zaina S; Lund G
    J Nutrigenet Nutrigenomics; 2011; 4(5):261-74. PubMed ID: 22353663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetics of Atherosclerosis: Emerging Mechanisms and Methods.
    Khyzha N; Alizada A; Wilson MD; Fish JE
    Trends Mol Med; 2017 Apr; 23(4):332-347. PubMed ID: 28291707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic Regulation of Endothelial Cell Function by Nucleic Acid Methylation in Cardiac Homeostasis and Disease.
    Russell-Hallinan A; Watson CJ; O'Dwyer D; Grieve DJ; O'Neill KM
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):1025-1044. PubMed ID: 32748033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetics and cell cycle regulation in cystogenesis.
    Li X
    Cell Signal; 2020 Apr; 68():109509. PubMed ID: 31874209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic effects of physical activity in elderly patients with cardiovascular disease.
    Recchioni R; Marcheselli F; Antonicelli R; Mensà E; Lazzarini R; Procopio AD; Olivieri F
    Exp Gerontol; 2017 Dec; 100():17-27. PubMed ID: 29074290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic reprogramming in atherosclerosis.
    Grimaldi V; Vietri MT; Schiano C; Picascia A; De Pascale MR; Fiorito C; Casamassimi A; Napoli C
    Curr Atheroscler Rep; 2015; 17(2):476. PubMed ID: 25433555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases.
    Schiano C; Benincasa G; Franzese M; Della Mura N; Pane K; Salvatore M; Napoli C
    Pharmacol Ther; 2020 Jun; 210():107514. PubMed ID: 32105674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emergent expansion of clinical epigenetics in patients with cardiovascular diseases.
    Napoli C; Coscioni E; de Nigris F; Donatelli F
    Curr Opin Cardiol; 2021 May; 36(3):295-300. PubMed ID: 33605616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA methylation map of human atherosclerosis.
    Zaina S; Heyn H; Carmona FJ; Varol N; Sayols S; Condom E; Ramírez-Ruz J; Gomez A; Gonçalves I; Moran S; Esteller M
    Circ Cardiovasc Genet; 2014 Oct; 7(5):692-700. PubMed ID: 25091541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetics and cardiovascular risk in childhood.
    Martino F; Magenta A; Pannarale G; Martino E; Zanoni C; Perla FM; Puddu PE; Barillà F
    J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):539-46. PubMed ID: 27367935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction Between microRNA and DNA Methylation in Atherosclerosis.
    Tao J; Xia L; Cai Z; Liang L; Chen Y; Meng J; Wang Z
    DNA Cell Biol; 2021 Jan; 40(1):101-115. PubMed ID: 33259723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From air pollution to cardiovascular diseases: the emerging role of epigenetics.
    Micheu MM; Birsan MV; Szép R; Keresztesi Á; Nita IA
    Mol Biol Rep; 2020 Jul; 47(7):5559-5567. PubMed ID: 32506306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.